Antithrombotic therapy in atrial fibrillation.
Publication
, Chapter
Albers, GW; Dalen, JE; Laupacis, A; Manning, WJ; Petersen, P; Singer, DE
January 2001
Duke Scholars
DOI
Publication Date
January 2001
Volume
119
Start / End Page
194S / 206S
Related Subject Headings
- Stroke
- Risk Assessment
- Respiratory System
- Platelet Aggregation Inhibitors
- Outcome Assessment, Health Care
- Intracranial Hemorrhages
- Humans
- Fibrinolytic Agents
- Electric Countershock
- Atrial Fibrillation
Citation
APA
Chicago
ICMJE
MLA
NLM
Albers, G. W., Dalen, J. E., Laupacis, A., Manning, W. J., Petersen, P., & Singer, D. E. (2001). Antithrombotic therapy in atrial fibrillation. (Vol. 119, pp. 194S-206S). https://doi.org/10.1378/chest.119.1_suppl.194s
Albers, G. W., J. E. Dalen, A. Laupacis, W. J. Manning, P. Petersen, and D. E. Singer. “Antithrombotic therapy in atrial fibrillation.,” 119:194S-206S, 2001. https://doi.org/10.1378/chest.119.1_suppl.194s.
Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. In 2001. p. 194S-206S.
Albers, G. W., et al. Antithrombotic therapy in atrial fibrillation. Vol. 119, 2001, pp. 194S-206S. Pubmed, doi:10.1378/chest.119.1_suppl.194s.
Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. 2001. p. 194S-206S.
DOI
Publication Date
January 2001
Volume
119
Start / End Page
194S / 206S
Related Subject Headings
- Stroke
- Risk Assessment
- Respiratory System
- Platelet Aggregation Inhibitors
- Outcome Assessment, Health Care
- Intracranial Hemorrhages
- Humans
- Fibrinolytic Agents
- Electric Countershock
- Atrial Fibrillation